Icahn Capital's George Hebard Named as Director on Enzon Pharma (ENZN) Board
Tweet
Share
E-mail
In a 13D filing after the close on Enzon Pharma (Nasdaq: ENZN), Carl Icahn disclosed the company's Board named George Hebard as a director. Hebard is a managing director at Icahn Capital LP.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mavis acquires Pep Boys from Icahn Enterprises for $700M
- Nu Skin EVP of global sales takes medical leave
- Yum! Brands adds former HanesBrands CEO to its board
Create E-mail Alert Related Categories
13Ds, Management ChangesRelated Entities
Carl Icahn, 13DSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
